These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 11282257)
1. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Schluger JH; Borg L; Ho A; Kreek MJ Neuropsychopharmacology; 2001 May; 24(5):568-75. PubMed ID: 11282257 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression. Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341 [TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. Schluger JH; Bart G; Green M; Ho A; Kreek MJ Neuropsychopharmacology; 2003 May; 28(5):985-94. PubMed ID: 12700714 [TBL] [Abstract][Full Text] [Related]
4. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence. Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768 [TBL] [Abstract][Full Text] [Related]
5. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts. Nava F; Manzato E; Lucchini A Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429 [TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients. Gerra G; Leonardi C; Cortese E; Zaimovic A; Dell'Agnello G; Manfredini M; Somaini L; Petracca F; Caretti V; Baroni C; Donnini C Addict Biol; 2008 Mar; 13(1):95-104. PubMed ID: 18201294 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trial. Walter M; Gerber H; Kuhl HC; Schmid O; Joechle W; Lanz C; Brenneisen R; Schächinger H; Riecher-Rössler A; Wiesbeck GA; Borgwardt SJ J Clin Psychopharmacol; 2013 Apr; 33(2):193-8. PubMed ID: 23422375 [TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts. Nava F; Caldiroli E; Premi S; Lucchini A J Addict Dis; 2006; 25(2):9-16. PubMed ID: 16785214 [TBL] [Abstract][Full Text] [Related]
12. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence. Zhang GF; Ren YP; Sheng LX; Chi Y; Du WJ; Guo S; Jiang ZN; Xiao L; Luo XN; Tang YL; Smith AK; Liu ZQ; Zhang HX Am J Drug Alcohol Abuse; 2008; 34(6):760-8. PubMed ID: 19016181 [TBL] [Abstract][Full Text] [Related]
13. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397 [TBL] [Abstract][Full Text] [Related]
14. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Rotllant D; Armario A Neuroscience; 2005; 130(2):427-34. PubMed ID: 15664699 [TBL] [Abstract][Full Text] [Related]
16. HPA axis activation in major depression and response to fluoxetine: a pilot study. Young EA; Altemus M; Lopez JF; Kocsis JH; Schatzberg AF; DeBattista C; Zubieta JK Psychoneuroendocrinology; 2004 Oct; 29(9):1198-204. PubMed ID: 15219644 [TBL] [Abstract][Full Text] [Related]
17. Metyrapone effects on beta-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in man. Vescovi PP; Gerra G; Maninetti L; Pedrazzoni M; Michelini M; Pioli G; Girasole G; Caccavari R; Maestri D; Passeri M Neuropeptides; 1990 Mar; 15(3):129-32. PubMed ID: 2174517 [TBL] [Abstract][Full Text] [Related]
18. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Buckley TM; Mullen BC; Schatzberg AF Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187 [TBL] [Abstract][Full Text] [Related]
19. Associations among hypothalamus-pituitary-adrenal axis function, novelty seeking, and retention in methadone maintenance therapy for heroin dependency. Lin SH; Chen WT; Chen KC; Lee SY; Lee IH; Chen PS; Yeh TL; Lu RB; Yang YK J Addict Med; 2013; 7(5):335-41. PubMed ID: 23896751 [TBL] [Abstract][Full Text] [Related]
20. Neurobiology of addictive behaviors and its relationship to methadone maintenance. Stimmel B; Kreek MJ Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]